Two-year outcomes of Sight Sciences’s Omni Surgical System for MIGS therapies were published in Clinical Ophthalmology. The data could help propel the company to the forefront of the MIGS market.
- Pain Points When Maintaining a Cleanroom
- Manufacturing Durable Diabetes Tech for the 21st Century
- Innovation in Patient Monitoring and Wearables
- More Layoffs Signal COVID-19 Testing Boom Is Over
- Increasing COVID Numbers in China Creates Uncertainty
- High-Quality (Level 4) PMCF Surveys: What Are They?